Skip to content
Catalyst

PapersPMID:25765835

Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial.

Phytomedicine2015The record ↗

findings
4
compound
1
endpoints
4
PMID:25765835
  1. Finding, very limited evidenceraisesSuperoxide dismutase activity
  2. Finding, very limited evidenceraisesGlutathione peroxidase activity
  3. Finding, very limited evidenceraisesTotal antioxidant capacity
  4. Finding, very limited evidencelowersC-reactive protein concentration
Study, every finding
RCT · 6 weeks
Dose studied, every finding
140 mg dried Silybum marianum extract three times daily for 45 days
  • “Silymarin supplementation significantly increased superoxide dismutase (SOD), glutathione peroxidase (GPX) activity and total antioxidant capacity (TAC) compared to patients taking the placebo, by 12.85%, 30.32% and 8.43%, respectively (p < 0.05).”
  • “There was a significant reduction in hs-CRP levels by 26.83% (p < 0.05) in the silymarin group compared to the placebo group.”
    Population
    adults aged 25-50 with type 2 diabetes mellitus on stable medication; fasting blood samples

Study record

Design
randomised controlled trial
Species
human
Population
type 2 diabetes patients aged 25-50 yr on stable medication (Tabriz, Iran)
Participants
40
Comparator
placebo
Duration
45 days
Endpoints measured
5